UK Health Officials Rebut Trump's Autism-Paracetamol Claim

US President Donald Trump's latest statement has led not only to widespread public discussion but also to a sensitive diplomatic situation in relations with the United Kingdom. Trump had claimed that the use of paracetamol during pregnancy is linked to the development of autism in children, which was immediately followed by a firm and unequivocal denial from the British side.

The UK's Health Secretary, Wes Streeting, made an urgent appeal, urging the British public to "pay no attention" to Donald Trump's claims. "There is no evidence linking the use of paracetamol by pregnant women to autism in their children," Streeting assured.

This direct and public intervention by the minister, which effectively questions the words of the US President, is unprecedented in the relations of allied countries. The "Financial Times" notes that this step by the minister will most likely be perceived negatively by the Trump administration, creating additional tension.

Dr. Alison Cave, the Chief Safety Officer of the UK's Medicines and Healthcare products Regulatory Agency (MHRA), also came out in support of the minister's words. She reaffirmed the current medical guidelines, stating that paracetamol remains the officially recommended remedy for pain relief for pregnant women.

According to her, the available scientific data do not allow for the establishment of any causal link between paracetamol and autism. The British healthcare system continues to be guided by the principles of evidence-based medicine and calls on citizens to trust exclusively the opinions of specialists and official recommendations, avoiding unverified and potentially dangerous information spread by politicians.